CDC73 and neoplasm: Moreover, the observation that about half of the patients with PC, as well as half of those who had an aggressive tumor, do not carry a CDC73 mutation raises the question of whether large CDC73 gene deletions (27) or alterations of its promoter methylation (28, 29), or other yet unknown predisposing genes might be involved.